BOOK A DEMO

About Us

We help healthcare teams navigate complexity, understand influence, and make decisions that drive meaningful healthcare outcomes.

About Neolytica

Neolytica, a subsidiary of QPharma, offers innovative technology solutions that leverage data science and artificial intelligence. The KOL mapping platform with sentiment analysis enables organizations to measure the impact of their medical message and optimize their commercial and medical affairs strategies- delivering significant strategic and operational value.

Book A Demo

MISSION STATEMENT

Neolytica provides solutions that improve global life science organizations’ strategies and lead to actionable insights. Our vision is to help biopharma companies gain an unprecendented level of support by identifying the stakeholders and KOLs that are relevant and necessary to their strategic efforts.

Core Values

Our values guide how we build our platforms, work with our partners, and show up for the healthcare ecosystem. They shape our decisions, our standards, and our commitment to delivering intelligence that can be trusted.

01.

Quality

We serve as stewards of quality — both in the delivery of our own compliance solutions, and in the innovative products and offerings we help our clients bring to market.

02.

Accountability

We hold our leadership, our personnel, our partners, and our clients to the highest standards — recognizing that we work together in serving patients and healthcare professionals who rely upon us. ​

03.

Dependability

We acknowledge that our company’s reputation depends on the empowerment of every individual to respond efficiently, to make decisions quickly, and to perform proactively in service to our clients.

04.

Responsibility

We stand firmly behind our commitments — to serve our clients to the best of our ability, to engage with our community as good corporate citizens, and to demonstrate caring and concern for the lives of our employ KOLs and their families. ​

Numbers driving a brighter future.

Turning vast scientific data into actionable intelligence

Neolytica continuously analyzes millions of publications, clinical trials, grants, conferences, digital platforms, and clinical guidelines to uncover what truly matters. By connecting these signals in context, we help healthcare teams cut through complexity, understand influence, and make informed decisions with confidence.
Publications
0 M+
Grants
0 K+
Conference
0 K+
Trials
0 M+
Digital Platforms
0 K+
Guidelines
0 K+

Meet the People Behind the Vision

Our leadership team brings together deep expertise across life sciences, technology, and healthcare strategy. Guided by experience and purpose, they shape Neolytica’s vision to deliver intelligence that drives real-world impact.

Badal Shah

Founder & President

Founder & President of Neolytica, Badal Shah, is a Gold Stevie Award 2025 winner for Technology Excellence and a Top 100 Healthcare Technology Leader. A Forttuna Global Excellence Awards® honoree, his journey has been featured on a Times Square billboard. He is also a published researcher and a full member of the Sigma Xi Honors Society.

Linkedin

Achelle Paul

VP, Data and Research

Amit Sepaha

Technical Product Owner

Dr. Joseph M. Chalil

Medical Advisor

Panagiotis Gerolymatos

Director Data Science

Rick Johansen

Vice President of Sales

Dr. Wasif Masood

Head of R & D

Join Our Team

We’re always looking for curious minds and passionate hearts to grow with us. If you’re ready to make an impact and be part of something meaningful, we’d love to hear from you.

Apply now
  • Webinar

Holistic Insights for Medical & Commercial Teams: Viewing the HCPs an Integrated Lens

Transform HCP insights into Impact- A Masterclass with Industry leaders is a webinar series crafted to bring together prominent thought leaders and experts to explore the transformative topics that are shaping the Key External Expert (KEE) engagement insights generating impact measurement and precision communication between pharma and HCPs.
View All

Blogs

Blog

Why Real-Time Intelligence Is Replacing Static Dashboards in Medical Affairs

For years, dashboards have been the standard way Medical Affairs teams monitor expert activity, scientific conversations, and engagement performance. They
Read More

Blog

Why Experts Don’t Fit Neatly Into Lists Anymore

Static expert lists can’t capture shifting influence in today’s fast-moving healthcare environment. With a dynamic KOL database and advanced KOL
Read More

Blog

Why Sentiment Tags Are the Missing Layer in Speaker Selection

Speaker selection has traditionally followed a familiar pattern: identify well-known experts, validate credentials, and build programs around visibility and reputation.
Read More

Blog

Beyond the Usual Names: Why Local Influence Deserves a Closer Look

Neolytica blends KOL sentiment analysis, behavioral insights, and network mapping to reveal influential local clinicians, improving pharma engagement and strategy.
Read More

Blog

360-Degree Mapping for a 360-Degree Message: How Neolytica Aligns Strategy Across Medical and Commercial Teams

Medical and commercial teams rarely disagree on objectives. Both want relevant conversations, credible science, and measurable impact. Yet in practice,
Read More
From Strategy to Suggestion: How Ti Expert Makes Expert Engagement Measurable From Strategy to Suggestion: How Ti Expert Makes Expert Engagement Measurable

Blog

From Strategy to Suggestion: How Ti Expert Makes Expert Engagement Measurable

Field and medical teams spend countless hours planning who to meet, what to discuss, and how to advance scientific conversations.
Read More
View All Blogs
Scroll to Top

Get in Touch

Badal Shah

Badal Shah has transformed the approach to affecting successful outcomes inside the arena of thought leadership within health and life sciences. It was his vision to start a subsidiary company completely focused on Data analytics and Artificial intelligence. He will be the Managing Director of Neolytica and responsible for its growth and P&L.

  • Recognized as “Top 100 Healthcare leaders” by International Forum on Advancement in Healthcare (IFAH) and was also nominated for “Forbes 30 under 30” in Healthcare in 2018.
  • Pioneered the innovative approach of “How to achieve effective medical communication and optimize field force during pre and post drug launches” supporting numerous successful drug launches.
  • He was also part of the team to establish KOL mapping business at Veeva systems, before joining QPharma.